Well at a minimum it raises the question if they are raising capital on insider knowledge. The ball is in Anavex court until the end of the clock stop. When is the next review cycle? The best interest of shareholders if confidence is weak is to raise capital to continue additional trials. Theories about needing to raise capital to go to market are weak, if approved there will be no issue raising capital at higher prices. Why raise capital now except to hedge future position?
Market Data 
Markets 
AI
